Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells

Biomaterials

Volumn 33, Issue 19, 2012, Pages 4792-4800

  Prokoph, Silvana ^a   Chavakis, Emmanouil ^b   Levental, Kandice R ^a   Zieris, Andrea ^a   Freudenberg, Uwe ^a   Dimmeler, Stefanie ^b   Werner, Carsten ^a  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Biohybrid hydrogel; Cardiac tissue engineering; Chemotaxis; Endothelial progenitor cell; Stromal cell derived factor 1

Indexed keywords

ANGIOGENESIS; CARDIAC REGENERATION; CARDIAC TISSUE ENGINEERING; CHEMOATTRACTANTS; CHEMOKINES; CHEMOTAXIS; CONCENTRATION GRADIENTS; ENDOTHELIAL PROGENITOR CELLS; FUNCTIONALIZED; IN-VITRO; ISCHEMIC TISSUES; LOADING CONCENTRATION; MATRIX METALLOPROTEASE; MYOCARDIAL INFARCTION; PROGENITOR CELL; SULFATED GLYCOSAMINOGLYCANS; THERAPEUTIC STRATEGY; VASCULARIZATION;

BIOCHEMISTRY; GELS; HEART VALVE PROSTHESES; LOADING; POLYSACCHARIDES; TISSUE; TISSUE ENGINEERING;

HYDROGELS;

HEPARIN; MATRIX METALLOPROTEINASE; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL HOMING; CELL INFILTRATION; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; VASCULARIZATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS; ENDOTHELIAL CELLS; HEPARIN; HUMANS; HYDROGELS; MICE; MICE, NUDE; STEM CELLS;

MUS;

EID: 84859838205     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.03.039     Document Type: Article

References (48)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American heart association. Circulation 2011, 123:e18-e209.
2. Dimmeler S., Burchfield J., Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008, 28:208-216.
3. Wang F., Guan J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv Drug Deliv Rev 2010, 62:784-797.
4. Bouten C.V.C., Dankers P.Y.W., Driessen-Mol A., Pedron S., Brizard A.M., Baaijens F.P.T. Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev 2011, 63(4-5):221-241.
5. Venugopal J.R., Prabhakaran M.P., Mukherjee S., Ravichandran R., Dan K., Ramakrishna S. Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface 2012, 9(66):1-19.
6. Davis M.E., Hsieh P.C.H., Grodzinsky A.J., Lee R.T. Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005, 97:8-15.
7. Sapir Y., Kryukov O., Cohen S. Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 2011, 32(7):1838-1847.
8. Chavakis E., Dimmeler S. Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal 2011, 15(4):967-980.
9. Takahashi M. Role of the SDF-1/CXCR4 system in myocardial infarction. Circ J 2010, 74:418-423.
10. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104(12):3472-3482.
11. Sadir R., Baleux F., Grosdidier A., Imberty A., Lortat-Jacob H. Characterization of the stromal cell-derived factor-1α-heparin complex. J Biol Chem 2001, 276(11):8288-8296.
12. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
13. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
14. Burchfield J.S., Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008, 1(1):4.
15. Ballard V.L.T., Edelberg J.M. Stem cells and the regeneration of the aging cardiovascular system. Circ Res 2007, 100:1116-1127.
16. Chavakis E., Koyanagi M., Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 2010, 121:325-335.
17. Sundararaman S., Miller T.J., Pastore J.M., Kiedrowski M., Aras R., Penn M.S. Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther 2011, 18(9):867-873.
18. Segers V.F., Tokunou T., Higgins L.J., MacGillivray C., Gannon J., Lee R.T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116(15):1683-1692.
19. Ratanavaraporn J., Furuya H., Kohara H., Tabata Y. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 2011, 32(11):2797-2811.
20. Kuraitis D., Zhang P., Zhang Y., Padavan D.T., McEwan K., Sofrenovic T., et al. A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater 2011, 22:109-123.
21. Rabbany S.Y., Pastore J., Yamamoto M., Miller T., Rafii S., Aras R., et al. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 2010, 19(4):399-408.
22. Wang Y., Irvine D.J. Engineering chemoattractant gradients using chemokine-releasing polysaccharide microspheres. Biomaterials 2011, 32(21):4903-4913.
23. Sobkow L., Seib F.P., Prodanov L., Kurth I., Drichel J., Bornhäuser M., et al. Prolonged transendothelial migration of human haematopoietic stem and progenitor cells (HSPCs) towards hydrogel-released SDF1. Ann Hematol 2011, 90(8):865-871.
24. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.Y., Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31(14):3997-4008.
25. He X., Ma J., Jabbari E. Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels. Int J Pharm 2010, 390(2):107-116.
26. Sommer J.U., Dockhorn R., Welzel P., Freudenberg U., Werner C. Swelling equilibrium of a binary polymer gel. Macromolecules 2011, 44:981-986.
27. Freudenberg U, Sommer JU, Levental KR, Welzel PB, Zieris A, Chwalek K, et al. Using mean field theory to guide biofunctional materials design. Adv Funct Mater. , in press. doi:10.1002/adfm.201101868.
28. Zieris A., Prokoph S., Levental K.R., Welzel P.B., Grimmer M., Freudenberg U., et al. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 2010, 31(31):7985-7994.
29. Chwalek K., Levental K.R., Tsurkan M.V., Zieris A., Freudenberg U., Werner C. Two-tier hydrogel degradation to boost endothelial cell morphogenesis. Biomaterials 2011, 32(36):9649-9657.
30. Zieris A., Chwalek K., Prokoph S., Levental K.R., Welzel P.B., Freudenberg U., et al. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels. J Control Release 2011, 156(1):28-36.
31. Freudenberg U., Hermann A., Welzel P.B., Stirl K., Schwarz S.C., Grimmer M., et al. A starPEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials 2009, 30:5049-5060.
32. Tsurkan M.V., Levental K.R., Freudenberg U., Werner C. Enzymatically degradable heparin-polyethylene glycol gels with controlled mechanical properties. Chem Commun 2010, 46:1141-1143.
33. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest;108:391-7.
34. Lanfer B., Freudenberg U., Zimmermann R., Stamov D., Körber V., Werner C. Aligned fibrillar collagen matrices obtained by shear flow deposition. Biomaterials 2008, 28:3888-3895.
35. McFadden G., Kelvin D. New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road. Biochem Pharmacol 1997, 54:1271-1280.
36. Amara A., Lorthioir O., Valenzuela A., Magerus A., Thelen M., Montes M., et al. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 1999, 274(34):23916-23925.
37. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997, 16(23):6996-7007.
38. Netelenbos T., Zuijderduijn S., van den Born J., Kessler F.L., Zweegman S., Huijgens P.C., et al. Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol 2002, 72:353-362.
39. Carr A.N., Howard B.W., Yang H.T., Eby-Wilkens E., Loos P., Varbanov A., et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc Res 2006, 69(4):925-935.
40. Alsayed Y., Ngo H., Runnels J., Leleu X., Singha U.K., Pitsillides C.M., et al. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 2007, 109(7):2708-2717.
41. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112(11):1618-1627.
42. De La Luz Sierra M., Yang F., Narazaki M., Salvucci O., Davis D., Yarchoan R., et al. Differential processing of stromal-derived factor-1a and stromal-derived factor-1 b explains functional diversity. Blood 2004, 103(7):2452-2459.
43. Sadir R., Imberty A., Baleux F., Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004, 279(42):43854-43860.
44. Kim C.H., Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 1998, 91(1):100-110.
45. Szmitko P.E., Fedak P.W.M., Weisel R.D., Stewart D.J., Kutryk M.J.B., Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 2003, 107:3093-3100.
46. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
47. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
48. Doyle B., Sorajja P., Hynes B., Kumar A.H.S., Araoz P.A., Stalboerger P.G., et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev 2008, 17(5):941-951.